Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo to Report Second Quarter Financial Results on August 6, 2024

Tuesday, July 30, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. has announced it will report its financial results for the second quarter of 2024 on August 6. The report will cover the period ending June 30, 2024. As a company specializing in wearable medical robotics, Myomo aims to enhance functionality for individuals with neurological disorders and upper-limb paralysis.
Price reaction · baseline $4.39 (2024-07-30T16:03:00.000Z) · hit during market hours · clean, no other MYO news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is actively reporting its financial results.
  • The company focuses on innovative solutions for neurological disorders.
  • The upcoming report may provide insights into the company's growth.

Full Press Release Details

BOSTON (July 30, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2024 on August 6, 2024. ( Read more )

Frequently Asked Questions

When will Myomo report its Q2 financial results?

Myomo will report its Q2 financial results on August 6, 2024.

What period do the financial results cover?

The financial results will cover the period ending June 30, 2024.

What does Myomo specialize in?

Myomo specializes in wearable medical robotics for neurological disorders.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo financial results Q2 2024 wearable robotics neurological disorders
Last updated: Jul 30, 2024

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk